Residential Collegefalse
Status已發表Published
Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): An empirical study from Wuhan, Hubei Province, China
Luo,Erdan1; Zhang,Daiyan1; Luo,Hua1; Liu,Bowen1; Zhao,Keming2,3; Zhao,Yonghua1; Bian,Ying1; Wang,Yitao1
2020-04-15
Source PublicationChinese Medicine
ISSN1749-8546
Volume15Pages:34
Abstract

Background: A novel coronavirus was identified in December, 2019 in Wuhan, China, and traditional Chinese medicine (TCM) played an active role in combating the novel coronavirus pneumonia (NCP) caused by this fast-spreading virus COVID-19. Thus, we aimed to explore TCM characteristics of clinical efficacy to NCP, as well as to optimize Qingfei Paidu decoction (QFPDD) and the recommended formulas to NCP by National Health Commission (NHC). Methods: Chinese medical sciences theory and clinical application of TCM were analyzed. A total of 54 NCP patients were observed in a hospital from Wuhan, whose clinical characteristics and utilization of Chinese Medicines (CMs) were described. Paired t test was used to measure the change of patients' hemogram during hospitalization period, indicating the effect of CMs. Multiple linear regression analysis was applied to explore the factors affecting the length of hospital stay. Network pharmacology analysis was applied to figure out the performance of NHC-recommended formulas of five disease stages at levels of compounds, targets and pathways. Result: The average length of hospital stay was 8.96 days. Patients over 45 stayed 9.79 days in hospital in average, longer than 7.64 days of patients under 45. Comparing the hemograms between admission and discharge of hospital, the number of leukocytes, neutrophil, lymphocyte and platelet increased, while the numbers of erythrocytes, hemoglobin concentration and hematocrit decreased. According to the standard coefficients of regression, the factor affecting the length of stay for the most was CMs in category of invigorating spleen and removing dampness (ISRD), followed by administrating CMs, male, and cough. Thirty-two CMs were screened after deleting duplication from QFPDD and NHC-recommended formulas. Compound quercetin, luteolin, kaempferol, acacetin etc., were all involved in the treatment of various disease stages on the compound level both in generality and individuality. Conclusion: TCM has a systemic theoretical understanding on the pathological evolution and a positive clinical efficacy on NCP. The CMs of ISRD improved patients' recovery, suggesting the importance of regulating intestinal function and keeping microenvironmental balance in TCM treatment of NCP. The active compounds from QFPDD and NHC-recommended formulas contribute to recovery of varied disease progresses during TCM treating NCP.

KeywordEmpirical Study Novel Coronavirus Pneumonia Traditional Chinese Medicine Treatment Efficacy Wuhan China
DOI10.1186/s13020-020-00317-x
URLView the original
Indexed BySCIE
Language英語English
WOS Research AreaIntegrative & Complementary Medicine ; Pharmacology & Pharmacy
WOS SubjectIntegrative & Complementary Medicine ; Pharmacology & Pharmacy
WOS IDWOS:000528746300001
PublisherBMC, CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
Scopus ID2-s2.0-85083864199
Fulltext Access
Citation statistics
Document TypeJournal article
CollectionTHE STATE KEY LABORATORY OF QUALITY RESEARCH IN CHINESE MEDICINE (UNIVERSITY OF MACAU)
Institute of Chinese Medical Sciences
Corresponding AuthorZhao,Yonghua; Bian,Ying
Affiliation1.State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau,Macao
2.First Affiliated Hospital,Liaoning University of Traditional Chinese Medicine,Shenyang,China
3.Medical Treatment Expert Group to Support for Covid-19 Control in Jihe Hospital,Wuhan,Caidian District,Hubei province,China
First Author AffilicationInstitute of Chinese Medical Sciences
Corresponding Author AffilicationInstitute of Chinese Medical Sciences
Recommended Citation
GB/T 7714
Luo,Erdan,Zhang,Daiyan,Luo,Hua,et al. Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): An empirical study from Wuhan, Hubei Province, China[J]. Chinese Medicine, 2020, 15, 34.
APA Luo,Erdan., Zhang,Daiyan., Luo,Hua., Liu,Bowen., Zhao,Keming., Zhao,Yonghua., Bian,Ying., & Wang,Yitao (2020). Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): An empirical study from Wuhan, Hubei Province, China. Chinese Medicine, 15, 34.
MLA Luo,Erdan,et al."Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): An empirical study from Wuhan, Hubei Province, China".Chinese Medicine 15(2020):34.
Files in This Item: Download All
File Name/Size Publications Version Access License
NCP1.pdf(3256KB)期刊论文作者接受稿开放获取CC BY-NC-SAView Download
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Luo,Erdan]'s Articles
[Zhang,Daiyan]'s Articles
[Luo,Hua]'s Articles
Baidu academic
Similar articles in Baidu academic
[Luo,Erdan]'s Articles
[Zhang,Daiyan]'s Articles
[Luo,Hua]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Luo,Erdan]'s Articles
[Zhang,Daiyan]'s Articles
[Luo,Hua]'s Articles
Terms of Use
No data!
Social Bookmark/Share
File name: NCP1.pdf
Format: Adobe PDF
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.